BioSpace News Archive

Business

Histogenics Corporation Announces Third Quarter 2017 Financial and Operating Results

Loss from operations was $(5.7) million in the third quarter of 2017, compared to $(6.6) million in the third quarter of 2016.

November 9, 2017
·
9 min read
Drug Development

Bavarian Nordic Announces Initiation of Phase II Booster Study of its Universal RSV Vaccine

This study is designed to help determine whether a single shot administration of vaccine is required annually, or if it remains effective over multiple seasons.

November 9, 2017
·
3 min read
Business

Catalyst Pharmaceuticals Announces Third Quarter 2017 Financial Results and Provides Corporate Update

For the quarter ended September 30, 2017, Catalyst reported a GAAP net loss of $4,177,649, or $0.05 per basic and diluted share, compared to a GAAP net loss of $3,953,981.

November 9, 2017
·
11 min read
Business

Thermo Fisher Declares Quarterly Dividend

Thermo Fisher Scientific today announced that its board of directors declared a quarterly cash dividend of $0.15 per share

November 9, 2017
·
1 min read
Business

Eleven Biotherapeutics to Report Third Quarter 2017 Financial Results on November 14, 2017

Eleven Biotherapeutics announced it will host a live conference call and webcast at 4:30 p.m. ET on Tuesday, November 14, 2017 to report its third quarter 2017 financial results and provide a corporate update.

November 9, 2017
·
1 min read
Business

Qu Biologics Recruits Ms. Jennifer Archibald, Chief Financial Officer, and Mr. Alun Rees, VP, Manufacturing, to Leadership Team

Ms. Jennifer Archibald has joined Qu Biologics in the role of Chief Financial Officer (CFO) to head up the company’s financial and accounting operations.

November 9, 2017
·
5 min read
Business

Adamas Announces New Employment Inducement Grant - Nov. 9, 2017

The company’s board of directors granted five new employees the option to purchase an aggregate of 15,300 shares of the company’s common stock, at a per share exercise price of $27.00.

November 9, 2017
·
1 min read
Business

Crown Bioscience Announcing the 2017 Board of Directors Election Results

Dr. Guoliang Yu re-elected as the Chairman.

November 9, 2017
·
2 min read
Genetown

Sarepta Therapeutics Prices $475M of Convertible Senior Notes Due 2024

Chief executive officer purchases approximately $2 million of shares of Sarepta’s common stock.

November 9, 2017
·
7 min read
Business

Cocrystal Pharma Announces Filing 2017 Third Quarter Financial Statements and Provides Company Update

Research and Development (R&D) expense during the second quarter was $1.39 million compared to $2.09 million for the same period in 2016.

November 9, 2017
·
4 min read